Market Overview:
The global Ossotide market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the Ossotide market can be attributed to factors such as rising incidence of fractures, increasing prevalence of osteoarthritis, and growing demand for ossotide injections in rheumatoid arthritis treatment. However, the high cost of ossotide therapies is likely to restrain the growth of this market during the forecast period. Based on type, the global Ossotide market can be segmented into ossotide tablets, ossosterone injections, and other types (including those that are used for veterinary purposes). The ossosterone injections segment is expected to account for a major share of the global Ossodore market during the forecast period owing to their high efficacy in treating fractures and other bone-related disorders.
Product Definition:
Ossotide is a mineral found in bones and teeth that helps to keep them strong. It is also important for the formation of new bone tissue.
Ossotide Tablets:
Ossotide (calcium phosphate tablets) is a medication used for the treatment of hereditary ossification disorder, which is also known as bone disease or osteogenesis imperfecta. It works by improving the body's absorption and use of calcium and phosphate in bones. Ossotide tablets are available in two forms - film-coated and non-film coated.
Ossotide Injections:
Ossotide injections are a medication used to treat muscular dystrophy, myasthenia gravis, and post-polio syndrome. It is also used as an immunosuppressive drug in the treatment of autoimmune diseases such as lupus. Ossotide injections are available in two forms: 2% (free base) and 4% (sodium salt).
Application Insights:
The osteoarthritis segment held the largest share of the global market in 2017. The growing geriatric population, coupled with rising prevalence of arthritis is factors responsible for high product penetration in this segment. According to a study published by the Centers for Disease Control and Prevention (CDC), around 54 million people aged 65 years or above were registered in 2015 across the globe. This number is expected to reach 78 million by 2030, thus presenting huge potential markets for drug manufacturers over the forecast period.
Rheumatoid arthritis accounted for a significant share as well as revenue growth rate on account of increasing disease prevalence and awareness about available treatment options among patients globally. Moreover, favorable government initiatives such as reimbursement coverage & joint funding from public-private partnerships are further anticipated to boost industry growth over forecast period. For instance, private health insurers in Australia cover up to 80% cost associated with medicines prescribed for rheumatoid arthritis which includes medication & supplements costs (by Health Insurance Commission).
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement scenario, and high healthcare expenditure are some of the major factors responsible for its dominance. In addition, increasing number of product launches is also expected to contribute towards regional growth over the forecast period.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast period owing to rising geriatric population and prevalence of osteoarthritis & rheumatoid arthritis (OA& RA) in this region as compared to other regions.
Growth Factors:
- Increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases is expected to drive the demand for Ossotide over the forecast period.
- Growing geriatric population is also anticipated to boost the market growth owing to increasing incidence of age-related bone disorders such as osteoporosis and arthritis.
- Rising awareness about benefits of Ossotide in prevention and treatment of bone disorders is projected to propel the market growth during the forecast period.
- Technological advancements in Ossotide production are likely to create new opportunities for market players over the next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Ossotide Market Research Report
By Type
Ossotide Tablets, Ossotide Injections, Ossotide for Injection
By Application
Fractures, Osteoarthritis, Rheumatism, Rheumatoid Arthritis
By Companies
Harbin Medisan, HeiLongJiang ZBD, Xinbai Pharmaceutical, Jiangshi Pharma, Jilin Huinan Huifa, Anhui Hongye Pharmaceutical, Tonghua Huikang, Changchun Puhua, Jilin Huakang Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
167
Number of Tables & Figures
117
Customization Available
Yes, the report can be customized as per your need.
Global Ossotide Market Report Segments:
The global Ossotide market is segmented on the basis of:
Types
Ossotide Tablets, Ossotide Injections, Ossotide for Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Fractures, Osteoarthritis, Rheumatism, Rheumatoid Arthritis
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Harbin Medisan
- HeiLongJiang ZBD
- Xinbai Pharmaceutical
- Jiangshi Pharma
- Jilin Huinan Huifa
- Anhui Hongye Pharmaceutical
- Tonghua Huikang
- Changchun Puhua
- Jilin Huakang Pharmaceutical
Highlights of The Ossotide Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Ossotide Tablets
- Ossotide Injections
- Ossotide for Injection
- By Application:
- Fractures
- Osteoarthritis
- Rheumatism
- Rheumatoid Arthritis
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ossotide Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ossotide is a molecule that has been found in meteorites. Ossotide is made up of carbon, oxygen, and nitrogen atoms.
Some of the major companies in the ossotide market are Harbin Medisan, HeiLongJiang ZBD, Xinbai Pharmaceutical, Jiangshi Pharma, Jilin Huinan Huifa, Anhui Hongye Pharmaceutical, Tonghua Huikang, Changchun Puhua, Jilin Huakang Pharmaceutical.
The ossotide market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ossotide Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Ossotide Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Ossotide Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Ossotide Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Ossotide Market Size & Forecast, 2018-2028
4.5.1 Ossotide Market Size and Y-o-Y Growth
4.5.2 Ossotide Market Absolute $ Opportunity
Chapter 5 Global Ossotide Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Ossotide Market Size Forecast by Type
5.2.1 Ossotide Tablets
5.2.2 Ossotide Injections
5.2.3 Ossotide for Injection
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Ossotide Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Ossotide Market Size Forecast by Applications
6.2.1 Fractures
6.2.2 Osteoarthritis
6.2.3 Rheumatism
6.2.4 Rheumatoid Arthritis
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Ossotide Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ossotide Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Ossotide Analysis and Forecast
9.1 Introduction
9.2 North America Ossotide Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Ossotide Market Size Forecast by Type
9.6.1 Ossotide Tablets
9.6.2 Ossotide Injections
9.6.3 Ossotide for Injection
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Ossotide Market Size Forecast by Applications
9.10.1 Fractures
9.10.2 Osteoarthritis
9.10.3 Rheumatism
9.10.4 Rheumatoid Arthritis
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Ossotide Analysis and Forecast
10.1 Introduction
10.2 Europe Ossotide Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Ossotide Market Size Forecast by Type
10.6.1 Ossotide Tablets
10.6.2 Ossotide Injections
10.6.3 Ossotide for Injection
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Ossotide Market Size Forecast by Applications
10.10.1 Fractures
10.10.2 Osteoarthritis
10.10.3 Rheumatism
10.10.4 Rheumatoid Arthritis
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Ossotide Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Ossotide Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Ossotide Market Size Forecast by Type
11.6.1 Ossotide Tablets
11.6.2 Ossotide Injections
11.6.3 Ossotide for Injection
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Ossotide Market Size Forecast by Applications
11.10.1 Fractures
11.10.2 Osteoarthritis
11.10.3 Rheumatism
11.10.4 Rheumatoid Arthritis
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Ossotide Analysis and Forecast
12.1 Introduction
12.2 Latin America Ossotide Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Ossotide Market Size Forecast by Type
12.6.1 Ossotide Tablets
12.6.2 Ossotide Injections
12.6.3 Ossotide for Injection
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Ossotide Market Size Forecast by Applications
12.10.1 Fractures
12.10.2 Osteoarthritis
12.10.3 Rheumatism
12.10.4 Rheumatoid Arthritis
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Ossotide Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Ossotide Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Ossotide Market Size Forecast by Type
13.6.1 Ossotide Tablets
13.6.2 Ossotide Injections
13.6.3 Ossotide for Injection
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Ossotide Market Size Forecast by Applications
13.10.1 Fractures
13.10.2 Osteoarthritis
13.10.3 Rheumatism
13.10.4 Rheumatoid Arthritis
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Ossotide Market: Competitive Dashboard
14.2 Global Ossotide Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Harbin Medisan
14.3.2 HeiLongJiang ZBD
14.3.3 Xinbai Pharmaceutical
14.3.4 Jiangshi Pharma
14.3.5 Jilin Huinan Huifa
14.3.6 Anhui Hongye Pharmaceutical
14.3.7 Tonghua Huikang
14.3.8 Changchun Puhua
14.3.9 Jilin Huakang Pharmaceutical
